Skip to Content

Akzo Nobel NV

AKZA: XAMS (NLD)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
€77.00CvnpxxsTvjshlzt

Inflation Bites AkzoNobel in Q3 but Not a Surprise; Shares Undervalued

Narrow-moat AkzoNobel reported third-quarter EBIT of EUR 325 million, down 26% versus 2020 but largely in line with Vara consensus. Shares are trading flat intraday. Raw material inflation drove the decline in profits as underlying demand remained strong. We’ve lowered our near-term estimates due to the raw materials headwind. However, we are raising our fair value estimate to EUR 107 from EUR 99 as we expect price increases to offset inflation over time and we now expect lower corporate costs in future. At current levels, the shares look undervalued.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of AKZA so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center